SPARROW IONIA HOSPITAL
1. Target Overview & Investment Thesis
SPARROW IONIA HOSPITAL is a 22-bed suburban community hospital in IONIA, MI with $65.0M in net patient revenue and a 9.7% operating margin. The hospital serves a payer mix of 24.3% Medicare, 2.7% Medicaid, and 73.1% commercial.
Thesis: Turnaround. Our ML models identify $4.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 9.7% to 17.0% (+736bps).
| Net Revenue HCRIS | $65.0M |
| Current EBITDA COMPUTED | $6.3M |
| Operating Margin COMPUTED | 9.7% |
| Occupancy HCRIS | 32.9% |
| Revenue / Bed COMPUTED | $3.0M |
| Net-to-Gross HCRIS | 40.0% |
| Distress Probability ML | 49.9% |
2. Market Context & Competitive Position
MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of 9.7% places it above the state median. Among 59 size-comparable peers (11-44 beds), the median margin is -1.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (11-44), prioritizing same-state peers. 59 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SPARROW IONIA HOSPITAL (Target) | MI | 22 | $65.0M | 9.7% |
| TRINITY HEALTH LIVINGSTON | MI | 42 | $200.4M | 15.2% |
| SPECTRUM HEALTH GERBER | MI | 25 | $116.2M | 16.0% |
| ST. FRANCIS HOSPITAL | MI | 25 | $106.2M | 7.8% |
| SPECTRUM HEALTH PENNOCK HOSPIT | MI | 25 | $96.5M | 11.1% |
| MUNSON HEALTHCARE GRAYLING HOS | MI | 42 | $87.2M | -10.3% |
| SPECTRUM HEALTH REED CITY | MI | 25 | $77.1M | 21.2% |
| SPARROW EATON | MI | 25 | $76.1M | 11.5% |
| MUNSON HEALTHCARE CHARLEVOIX H | MI | 25 | $73.6M | 1.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.8M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.4M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.3M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.3M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $791K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $42K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $6.3M |
| + RCM Uplift | +$4.8M |
| Pro Forma EBITDA | $11.1M |
| Current Margin | 9.7% |
| Pro Forma Margin | 17.0% |
| WC Released (1x) | $2.5M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $9.7M | $89.3M | 9.23x | 56.0% |
| Base (11x exit) | 10.0x | 11.0x | $9.7M | $101.4M | 10.48x | 60.0% |
| Bull Case | 9.0x | 11.0x | $8.7M | $120.3M | 13.82x | 69.1% |
| Bull (12x exit) | 9.0x | 12.0x | $8.7M | $133.8M | 15.37x | 72.7% |
| Bear Case | 11.0x | 10.0x | $10.6M | $62.3M | 5.85x | 42.4% |
| Bear (11x exit) | 11.0x | 11.0x | $10.6M | $72.0M | 6.76x | 46.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 32.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 59 hospitals with 11-44 beds
- Same-state prioritization (n=60)
- Comp margins: P25=-10.9% / P50=-1.3% / P75=9.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.